Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
93.41
(
-1.69%
)
Bitcoin
78,211.00
(
2.47%
)
News Focus
News Focus
Post# of 57798
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

enemem

Send PM Follow Ignore
Followers 4
Posts 1330
Boards Moderated 0
Alias Born 01/01/2007

enemem

Re: alertmeipp post# 34300

Thursday, 09/09/2010 8:36:22 AM

Thursday, September 09, 2010 8:36:22 AM

Post# of 57798
If the IND is approved, and CX1739 is used in clinical trials for ADHD, corx could turn around nicely. To a lesser extent, a good SA outcome would also offer a path to profitability.

This company is toast though, if it can't get its compounds approved for chronic use. That has to happen soon. All the new compounds are meaningless if none of them can be brought to the clinic.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today